A prospective observational trial on emesis in radiotherapy: Analysis of 1020 patients recruited in 45 Italian radiation oncology centres

Radiotherapy and Oncology

Volumn 94, Issue 1, 2010, Pages 36-41

  Maranzano, Ernesto ^a   De Angelis, Verena ^b   Pergolizzi, Stefano ^c   Lupattelli, Marco ^d   Frata, Paolo ^e   Spagnesi, Stefano ^f   Frisio, Maria Luisa ^g   Mandoliti, Giovanni ^h   Malinverni, Giuseppe ⁱ   Trippa, Fabio ^a   Fabbietti, Letizia ^j   Parisi, Salvatore ^k   Di Palma, Annamaria ^a   De Vecchi, Pietro ^l   De Renzis, Costantino ^m   Giorgetti, Celestino ⁿ   Bergami, Tiziano ^o   Orecchia, Roberto ^p   Portaluri, Maurizio ^q   Signor, Marco ^r   Di Gennaro, Davide ^s   more..

^a S MARIA HOSPITAL   (Italy)

^b Hospice   (Italy)

^c S Vincenzo Hospital   (Italy)

^d University Hospital   (Italy)

^e University Hospital   (Italy)

^f UNIVERSITY OF PISA   (Italy)

^g VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^h S MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

ⁱ CANDIOLO CANCER INSTITUTE   (Italy)

^j Azienda Ospedaliera Umberto I   (Italy)

^k CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^l FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^m UNIVERSITY OF MESSINA   (Italy)

ⁿ Hospital   (Italy)

^o C and G Mazzoni Hospital   (Italy)

^p EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^q A Perrino Hospital   (Italy)

^r SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^s S Giovanni di Dio   (Italy)

more..

Author keywords

Drug utilization review of antiemetics; Nausea; Radiation induced emesis; Vomiting

Indexed keywords

ANTIEMETIC AGENT; GRANISETRON; METOCLOPRAMIDE; ONDANSETRON; SEROTONIN ANTAGONIST; STEROID; TROPISETRON;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; EVALUATION; FACTORIAL ANALYSIS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; OBSERVATIONAL STUDY; ONCOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION INDUCED EMESIS; STATISTICAL SIGNIFICANCE;

ANTIEMETICS; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; NAUSEA; PROSPECTIVE STUDIES; RADIOTHERAPY; RISK FACTORS; VOMITING;

EID: 74549123750     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.11.001     Document Type: Article

References (23)

1. Prentice T. Radiation-induced emesis. Clinician 6 (1988) 40-43
2. Feyer P.C., Stewart A.L., and Titlbach O.J. Aetiology and prevention of emesis induced by radiotherapy. Support Care Cancer 6 (1998) 253-260
3. Goldsmith B. Antiemetic patterns of care for radiotherapy-induced nausea and vomiting (Abstr.). Proc Am Soc Clin Oncol (ASCO) 22 (2003) 740
4. Maranzano E., Feyer C.P., Molassiotis A., et al. Evidence-based recommendations for the use of antiemetics in radiotherapy. Radiother Oncol 76 (2005) 227-233
5. Kris M.G., Hesketh P.J., Somerfield M.R., et al. American Society of Clinical Oncology Guidelines for antiemetics in oncology: update 2006. J Clin Oncol 24 (2006) 2932-2947
6. Feyer C.P., Titlbach O.J., Wilkinson J., et al. Gastrointestinal reactions in radiotherapy (Abstr.). Support Care Cancer 3 (1996) 249
7. Priestman T.J., Roberts J.T., and Upadhyaya B.K. A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy. Clin Oncol 5 (1993) 358-363
8. Aass N., Hatun D.E., Thoresen M., et al. Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients. Radiother Oncol 5 (1997) 125-128
9. Spitzer T.R., Bryson J.C., Cirenza E., et al. Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation. J Clin Oncol 12 (1995) 2432-2438
10. Bey P., Wilkinson P.M., Resbeut M., et al. A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients. Support Care Cancer 4 (1996) 278-283
11. Sykes A.J., Kiltie A.E., and Stewart A.L. Ondansetron versus chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy. Support Care Cancer 5 (1997) 500-503
12. Prentice H.G., Cunningham S., Gandhi L., et al. Granisetron in the prevention of irradiation-induced emesis. Bone Marrow Transplant 15 (1995) 445-448
13. Ungerleider J.T., Andrysiak T.A., Fairbanks L.A., et al. Tetrahydrocannabinol vs prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy. Radiology 150 (1984) 598-599
14. The Italian Group for Antiemetic Research in Radiotherapy: radiation-induced emesis: a prospective observational multicenter Italian trial. Int J Radiat Oncol Biol Phys 44 (1999) 619-625
15. The Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC): prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol 17 (2006) 20-28
16. Feyer C.P., Maranzano E., Molassiotis A., et al. Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines. Support Care Cancer 13 (2005) 122-128
17. Horiot J.C. Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting?. Int J Radiat Oncol Biol Phys 60 (2004) 1018-1025
18. Tramer M.R., Reynolds D.J., Stoner N.S., et al. Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review. Eur J Cancer 34 (1998) 1836-1844
19. Maranzano E. Radiation-induced emesis: a problem with many open questions. Tumori 87 (2001) 213-218
20. Maranzano E. Prophylaxis of radiation-induced emesis. In: Donnerer J. (Ed). Antiemetic therapy (2003), Karger, Basel 179-191
21. Maranzano E., Bellavita R., De Angelis V., et al. Double-blind randomized clinical trial comparing prophylaxis vs. rescue treatment in patients undergoing fractionated upper abdomen radiotherapy (Abstr.). Radiother Oncol 73 (2004) S388
22. Enblom A., Axelsson B.B., Steineck G., Hammar M., and Börjeson S. One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient. Support Care Cancer 17 (2009) 23-32
23. Scarantino C.W., Ornitz R.D., Hoffman L.G., et al. Radiation-induced emesis: effects of ondansetron. Semin Oncol 6 (1992) 38-43